Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 15;5(3):460-461.
doi: 10.34197/ats-scholar.2023-0080OT. eCollection 2024 Sep 30.

Febrile Neutropenia

James F Lyon  1 , Mehrnaz Sadrolashrafi  2 , Margaret M Hayes  1
Affiliations

Febrile Neutropenia

James F Lyon et al. ATS Sch. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
An algorithm for empiric management of high-risk febrile neutropenia. CVC BSI = central venous catheter–related bloodstream infection; MDRO = multidrug-resistant organism; MRSA = methicillin-resistent Staphylococcus aureus; PCR = polymerase chain reaction; PNA = pneumonia; SSTI = skin and soft tissue infection; VRE = vancomycin-resistant enterococcus.
See this image and copyright information in PMC

References

    1. Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect . 2013;19:474–479. - PubMed
    1. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol . 2000;18:3038–3051. - PubMed
    1. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Infectious Diseases Society of America Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis . 2011;52:e56–e93. - PubMed
    1. Aguilar-Guisado M, Espigado I, Martín-Peña A, Gudiol C, Royo-Cebrecos C, Falantes J, et al. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial. Lancet Haematol . 2017;4:e573–e583. - PubMed
    1. Freifeld AG, Baden LR, Brown AE, Elting LS, Gelfand M, Greene JN, et al. National Comprehensive Cancer Network Fever and neutropenia clinical practice guidelines. J Natl Compr Canc Netw . 2004;2:390–432. - PubMed

LinkOut - more resources